These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10408566

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lethal capillary leak syndrome after a single administration of interferon beta-1b.
    Niederwieser G.
    Neurology; 2000 Apr 11; 54(7):1545-6. PubMed ID: 10751284
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interferon beta-1b.
    Goodkin DE.
    Lancet; 1994 Oct 15; 344(8929):1057-60. PubMed ID: 7934448
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interferon beta-1b for the treatment of multiple sclerosis.
    Petri T, Weber-Diehl F.
    J Biotechnol; 1995 Nov 21; 43(1):74-5. PubMed ID: 8573325
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
    Grossberg SE, Oger J, Grossberg LD, Gehchan A, Klein JP.
    J Interferon Cytokine Res; 2011 Mar 21; 31(3):337-44. PubMed ID: 21226608
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy].
    Ikeda K, Okamoto T, Yamamura T, Ohsawa I, Furutera R, Murata M.
    Rinsho Shinkeigaku; 2013 Mar 21; 53(1):19-23. PubMed ID: 23328061
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b.
    Borràs C, Río J, Porcel J, Barrios M, Tintoré M, Montalban X.
    Neurology; 1999 May 12; 52(8):1636-9. PubMed ID: 10331691
    [Abstract] [Full Text] [Related]

  • 16. Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis.
    Munschauer FE, Kinkel RP.
    Clin Ther; 1997 May 12; 19(5):883-93. PubMed ID: 9385477
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of an anti-IL-10 monoclonal antibody on rIFNbeta-1b-mediated immune modulation. Relevance to multiple sclerosis.
    Porrini AM, De Luca G, Gambi D, Reder AT.
    J Neuroimmunol; 1998 Jan 12; 81(1-2):109-15. PubMed ID: 9521612
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.